- Home
- DHIL vs BNTC Comparison
DHIL vs BNTC Comparison
Compare DHIL & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHIL
- BNTC
- Stock Information
- Founded
- DHIL 1990
- BNTC 1995
- Country
- DHIL United States
- BNTC United States
- Employees
- DHIL N/A
- BNTC N/A
- Industry
- DHIL Investment Managers
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- DHIL Finance
- BNTC Health Care
- Exchange
- DHIL Nasdaq
- BNTC Nasdaq
- Market Cap
- DHIL 384.0M
- BNTC 365.1M
- IPO Year
- DHIL 1995
- BNTC N/A
- Fundamental
- Price
- DHIL $131.68
- BNTC $13.12
- Analyst Decision
- DHIL
- BNTC Strong Buy
- Analyst Count
- DHIL 0
- BNTC 5
- Target Price
- DHIL N/A
- BNTC $26.60
- AVG Volume (30 Days)
- DHIL 26.5K
- BNTC 267.7K
- Earning Date
- DHIL 10-30-2025
- BNTC 11-12-2025
- Dividend Yield
- DHIL 4.61%
- BNTC N/A
- EPS Growth
- DHIL N/A
- BNTC N/A
- EPS
- DHIL 17.21
- BNTC N/A
- Revenue
- DHIL $149,665,296.00
- BNTC N/A
- Revenue This Year
- DHIL N/A
- BNTC N/A
- Revenue Next Year
- DHIL N/A
- BNTC N/A
- P/E Ratio
- DHIL $7.66
- BNTC N/A
- Revenue Growth
- DHIL 2.65
- BNTC N/A
- 52 Week Low
- DHIL $122.32
- BNTC $9.10
- 52 Week High
- DHIL $172.84
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- DHIL 40.07
- BNTC 39.88
- Support Level
- DHIL $130.11
- BNTC $11.54
- Resistance Level
- DHIL $133.58
- BNTC $13.89
- Average True Range (ATR)
- DHIL 2.58
- BNTC 1.26
- MACD
- DHIL 0.34
- BNTC -0.32
- Stochastic Oscillator
- DHIL 49.64
- BNTC 32.17
About DHIL Diamond Hill Investment Group Inc.
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.